Pfizer Colleagues to Mentor Veterans in Transition to Civilian Life
New York, N.Y., May 28, 2021 – Pfizer Inc. (NYSE: PFE) today announced a new partnership with American Corporate Partners (ACP), a national nonprofit organization dedicated to helping veterans and active duty spouses find their next careers through one-on-one mentoring, networking, and online career advice.
To mark this Memorial Day, Pfizer colleagues will join the ACP’s mentoring program. As mentors, Pfizer colleagues will assist program participants face the challenges associated with securing meaningful employment opportunities and develop long-term civilian careers. They will help veterans and eligible spouses throughout all stages of their job search, from developing a compelling resume to coaching them on effective interviewing and networking techniques.
“We are proud to join forces with ACP to provide veterans and their families the support, advice, and encouragement they need as they enter a new phase in their lives. Pfizer colleagues are well positioned to serve as mentors, based on their diverse backgrounds, unwavering dedication, and vast professional experience,” said Frank D’Amelio, Pfizer’s Chief Financial Officer & Executive Vice President of Global Supply. D’Amelio serves as Executive Sponsor of the Veterans in Pfizer (VIP) Colleague Resource Group.
Pfizer’s partnership with ACP kick-offs June 1st, 2021. Each Pfizer mentor pledges to a yearlong commitment that begins with a matching process, by which ACP’s staff personally pairs every applicant, hand-picking a Mentor for each Protégé based on career compatibility, experience level, location, and personal interests. Throughout the year, Pfizer mentors will hold one-on-one sessions, as well as virtual and in-person networking events as part of the program.
“We are so pleased that Pfizer has become an ACP partner. Pfizer has always supported the military community through its policies and programs. Providing mentors for ACP's program is another way that Pfizer will help veterans successfully transition from active duty service to meaningful civilian careers. We are thrilled to offer our participants access to guidance from mentors from one of the world's premier biopharmaceutical companies,” said Sid Goodfriend, ACP Founder and Chairman.
More than one million veterans are expected to transition from the military to civilian life over the next five years. Since it was founded in 2008, ACP has helped more than 20,000 veterans transition to civilian life.
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
About American Corporate Partners
American Corporate Partners (ACP) is a national nonprofit organization focused on helping returning veterans and active duty spouses find their next careers through one-on-one mentoring, networking and online career advice.
# # #
Pfizer Contact:
Media Relations
Sharon J. Castillo
+1 (212) 733-1226
[email protected]
12.19.2024
12.06.2024
12.04.2024
12.03.2024
11.27.2024